Tandem Diabetes Care Inc (TNDM)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$20.50

Buy

$22.38

arrow-up$0.42 (+2.00%)

Prices updated at 13 Dec 2025, 00:46 EST

Prices minimum 15 mins delay

Prices in USD

Tandem Diabetes Care Inc is a provider of medical care devices in the United States. Its products aid in the delivery of insulin and getting accurate readings through its software application.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Devices

Chairman

Ms. Rebecca B. Robertson

CEO

Mr. John F. Sheridan

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

2,650

Head office

12400 High Bluff Drive

San Diego

United States

92130

+1 858 366-6900

smorrison@tandemdiabetes.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Ms. Sandra Beaver Independent Director	-
Mr. Christopher J. Twomey Independent Director	0.08m
Mr. John F. Sheridan Director, President and Chief Executive Officer	0.73m
Mr. Rick Carpenter Chief Technical Officer	-
Ms. Peyton R. Howell Independent Director	0.07m
Ms. Susan Morrison Executive Vice President and Chief Administrative Officer	0.45m
Mr. Rajwant S. Sodhi Independent Director	0.07m
Ms. Leigh A. Vosseller Executive Vice President, Chief Financial Officer, Treasurer and Principal Accounting Officer	0.45m
Ms. Rebecca B. Robertson Chairman of the Board	0.12m
Ms. Elizabeth A. Gasser Executive Vice President and Chief Strategy and Product Officer	0.45m
Mr. Jean-Claude Kyrillos Executive Vice President and Chief Operating Officer	0.24m
Dr. Kathleen McGroddy-Goetz, PhD Independent Director	0.07m
Ms. Shannon Marie Hansen Executive Vice President, Chief Legal, Privacy and Compliance Officer and Secretary	-
Mr. Myoungil Cha Independent Director	0.06m
Mr. Joao Paulo Falcao Malagueira Independent Director	0.06m
Mr. Mark David Novara Executive Vice President and Chief Commercial Officer	0.45m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
BlackRock Inc	12,101,471
BlackRock, Inc.	11,110,645
Vanguard Group Inc	7,369,830
BlackRock Fund Advisors	7,357,186
Sessa Capital, L.P	5,000,000

Director dealings

Date chevron-l-regular chevron-r-regular	Action
16 Dec 2024	-
16 Dec 2024	-
16 Dec 2024	-
16 Dec 2024	-
16 Dec 2024	-
16 Dec 2024	-
21 Nov 2024	-
20 Nov 2024	-
15 Nov 2024	-
15 Nov 2024	-
15 Nov 2024	-
15 Nov 2024	-
15 Nov 2024	-
15 Nov 2024	-
15 Nov 2024	-
15 Nov 2024	-
15 Nov 2024	-
15 Nov 2024	-
15 Nov 2024	-
15 Nov 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.